Caredx Inc Stock Performance
| CDNA Stock | USD 13.35 0.33 2.53% |
The firm shows a Beta (market volatility) of 1.43, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CareDx will likely underperform. At this point, CareDx Inc has a negative expected return of -0.34%. Please make sure to confirm CareDx's maximum drawdown, kurtosis, day median price, as well as the relationship between the potential upside and daily balance of power , to decide if CareDx Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days CareDx Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 2.12 | Five Day Return 5.77 | Year To Date Return (39.50) | Ten Year Return 85.47 | All Time Return 43.87 |
1 | CareDx Reports Strong Q1 2025 Earnings Growth | 05/01/2025 |
2 | Disposition of 16700 shares by Cournoyer Christine of CareDx at 14.1275 subject to Rule 16b-3 | 05/06/2025 |
3 | CareDx, Inc Director Sells 235,971.00 in Stock | 05/09/2025 |
4 | Disposition of 1982 shares by Abhishek Jain of CareDx at 17.63 subject to Rule 16b-3 | 05/27/2025 |
5 | Disposition of 510 shares by Hagstrom William A of CareDx at 5.85 subject to Rule 16b-3 | 05/28/2025 |
6 | CareDx Announces Repurchase of 5 percent of Outstanding Shares CDNA Stock News | 06/03/2025 |
7 | Disposition of 2583 shares by Jeffrey Novack of CareDx at 19.52 subject to Rule 16b-3 | 06/06/2025 |
8 | Disposition of 4391 shares by Hagstrom William A of CareDx at 7.96 subject to Rule 16b-3 | 06/11/2025 |
9 | Acquisition by Torres Arthur A of 12103 shares of CareDx subject to Rule 16b-3 | 06/13/2025 |
10 | William A. Hagstrom Sells 19,391 Shares of CareDx, Inc Stock | 06/16/2025 |
11 | Disposition of 10000 shares by Peter Maag of CareDx at 19.242 subject to Rule 16b-3 | 06/17/2025 |
12 | Disposition of 10570 shares by Valantine Hannah of CareDx at 19.1642 subject to Rule 16b-3 | 06/18/2025 |
13 | Insider Selling Peter Maag Sells 10,000 Shares of CareDx Inc | 06/20/2025 |
14 | CareDx, Inc. Director Hannah Valantine Sells 10,570 Shares | 06/24/2025 |
15 | Disposition of 10000 shares by Peter Maag of CareDx at 18.5831 subject to Rule 16b-3 | 07/07/2025 |
16 | Acquisition by Goldberg Michael of 1218 shares of CareDx subject to Rule 16b-3 | 07/08/2025 |
17 | CareDx Stock Upgraded to Buy by Nephron Research CDNA Stock News | 07/09/2025 |
18 | Strong week for CareDx shareholders doesnt alleviate pain of five-year loss | 07/11/2025 |
19 | CareDx Inc Trading Down 3.35 percent on Jul 15 | 07/15/2025 |
20 | CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ ... | 07/18/2025 |
| Begin Period Cash Flow | 82.8 M | |
| Total Cashflows From Investing Activities | -483 K |
CareDx Relative Risk vs. Return Landscape
If you would invest 1,849 in CareDx Inc on April 24, 2025 and sell it today you would lose (547.00) from holding CareDx Inc or give up 29.58% of portfolio value over 90 days. CareDx Inc is currently does not generate positive expected returns and assumes 6.1976% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than CareDx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CareDx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CareDx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CareDx Inc, and traders can use it to determine the average amount a CareDx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0551
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CDNA |
Estimated Market Risk
| 6.2 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CareDx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CareDx by adding CareDx to a well-diversified portfolio.
CareDx Fundamentals Growth
CareDx Stock prices reflect investors' perceptions of the future prospects and financial health of CareDx, and CareDx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CareDx Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | -0.052 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 524.32 M | ||||
| Shares Outstanding | 55.68 M | ||||
| Price To Earning | (4.25) X | ||||
| Price To Book | 1.91 X | ||||
| Price To Sales | 2.09 X | ||||
| Revenue | 333.79 M | ||||
| Gross Profit | 234.31 M | ||||
| EBITDA | (33.99 M) | ||||
| Net Income | 52.55 M | ||||
| Cash And Equivalents | 306.22 M | ||||
| Cash Per Share | 5.73 X | ||||
| Total Debt | 28.37 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 6.84 X | ||||
| Cash Flow From Operations | 38.05 M | ||||
| Earnings Per Share | 1.12 X | ||||
| Market Capitalization | 724.96 M | ||||
| Total Asset | 491.05 M | ||||
| Retained Earnings | (626.24 M) | ||||
| Working Capital | 262.46 M | ||||
| Current Asset | 34.36 M | ||||
| Current Liabilities | 10.15 M | ||||
About CareDx Performance
By analyzing CareDx's fundamental ratios, stakeholders can gain valuable insights into CareDx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CareDx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CareDx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 64.93 | 44.01 | |
| Return On Tangible Assets | 0.13 | 0.13 | |
| Return On Capital Employed | 0.10 | 0.11 | |
| Return On Assets | 0.11 | 0.11 | |
| Return On Equity | 0.14 | 0.13 |
Things to note about CareDx Inc performance evaluation
Checking the ongoing alerts about CareDx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CareDx Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CareDx Inc generated a negative expected return over the last 90 days | |
| CareDx Inc has high historical volatility and very poor performance | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ ... |
- Analyzing CareDx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CareDx's stock is overvalued or undervalued compared to its peers.
- Examining CareDx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CareDx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CareDx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CareDx's stock. These opinions can provide insight into CareDx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CareDx Stock analysis
When running CareDx's price analysis, check to measure CareDx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareDx is operating at the current time. Most of CareDx's value examination focuses on studying past and present price action to predict the probability of CareDx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareDx's price. Additionally, you may evaluate how the addition of CareDx to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |